As part of the Appalachian Rural Health Institute (ARHI) Diabetes/Endocrine Center’s monthly Research Seminars, Charles J. Glueck, M.D., medical director of The Jewish Hospital Cholesterol Center, will lecture Thursday, May 5, in Grosvenor West 111 from noon to 1 p.m. Glueck’s lecture is sponsored by the offices of Alumni Affairs and Research.

Glueck has a 30-year track record in clinical research and patient care, specializing in the prevention of heart attacks and strokes. Glueck has written more than 500 scientific papers and is a key investigator for the American Heart Association. He also authored the chapter on cholesterol and heart disease in the “Merck Geriatric Manual.” 

Glueck will be lecturing on “Optimal Cholesterol Control in 2005.”

“Glueck is one of the world’s leading experts on the Metabolic Syndrome — an aggregate measure of risk factors for heart disease and type 2 diabetes, which includes obesity, hypertension, hyperlipidemia and glucose intolerance,” says Frank Schwartz, M.D., associate professor of endocrinology and director of the Diabetes/Endocrine Center.

“He will lecture on the role of lipid lowering medications and reduction in risk for heart disease or stroke. Glueck also will discuss clinical trials of drugs that have demonstrated the promise of reducing the risk of developing cardiovascular disease or stroke.”

His presentation will review the American Heart Association’s and National Cholesterol Education Program’s new target lipids levels for primary prevention and secondary prevention of stroke or adverse cardiovascular events, says Schwartz.

Beginning at 1 p.m. he will lecture second-year students as part of the reproduction block in their curriculum, focusing on young women with Metabolic Syndrome and Polycystic Ovary Syndrome (PCOS). PCOS is associated with irregular menses and infertility. Women with PCOS have a particularly high risk of miscarriage in their first trimester.

“His research has been instrumental in understanding the causes of early pregnancy loss in this condition and the treatments needed to prevent early pregnancy loss,” says Schwartz.

The ARHI Diabetes/Endocrine Center was founded by OU-COM and the College of Health and Human Services to further diabetes research, clinical training and care, and education. In addition to featuring national experts in the field of diabetes research, the seminars provide a forum for Ohio University researchers to learn about each other’s work and, hopefully, facilitate opportunities for more interdisciplinary and interdepartmental research collaborations.